"
Team:Groningen/Template/MODULE/project/MBD/results
From 2014.igem.org
(Difference between revisions)
Ottoschepers (Talk | contribs) |
Ottoschepers (Talk | contribs) |
||
| Line 45: | Line 45: | ||
<!-- TABLE SNIPPET OPTIONAL END--> | <!-- TABLE SNIPPET OPTIONAL END--> | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 00:17, 18 October 2014
Results
| Design | Tnisin | TAiiA | TDspB | Rating |
|---|---|---|---|---|
| 1 | 3 h | something | something | something |
| 2 | ? | After being applied to the wound. Amount of time for reaching the inhibitory concentrations of nisin, DspB and AiiA to pass the bottom membrane and into the wound. | ||
| 3 | tbd | In what quantity does S. aureus need to be detected? | ||
| 4 | tbd | In what quantity does P. aeruginosa need to be detected? | ||
| 5 | 2-16 ng/µL | This concentration can be used for both MRSA and VRE. Source: Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity ……. Brumfitt, Salton, Hamilton-Miller. | ||
| 6 | tbd | How much is needed to inhibit growth of PA/SA? |
Figure 1:
The best design for our purposes.
